Angola vs Ghana: The number of people with susceptibility test result for rifampicin
Angola
10,250
in 2021
Ghana
8,532
in 2021
Angola rank
21st
Ghana rank
24th
The number of people with susceptibility test result for rifampicin over time
- Angola
- Ghana
How they compare
Angola currently reports 10,250 against 8,532 in Ghana, a difference of 1,718.
That makes Angola's figure about 1.2 times Ghana's.
The two have swapped places 3 times across 5 shared years of data; in 2017 it was Ghana ahead.
Angola ranks 21st and Ghana ranks 24th of 155 countries.
Across the 2 decades both report, Angola averaged higher in 1 and Ghana in 1.
Head to head by decade
| Decade | Angola | Ghana | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 9,969 | 8,062 | 1,907 | Angola |
| 2020s | 5,672 | 8,274 | 2,602 | Ghana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Angola or Ghana?
- Angola, at 10,250 against 8,532 in Ghana as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Angola and Ghana?
- 1,718, with Angola ahead.
- How many years of comparable data are there for Angola and Ghana?
- 5 years are reported by both, from 2017 to 2021.
- How do Angola and Ghana rank globally for the number of people with susceptibility test result for rifampicin?
- Angola ranks 21st and Ghana ranks 24th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.